Your Health, We Care

Home > Photo Wall > Honor and qualification

Production approval for DIFICID

Release date: 2024-07-10 11:27:34     Recommended: 90

04L1089_24 非达霉素 批文_00.jpg04L1089_24 非达霉素 批文_00.jpg

DIFICID is suitable for treating Clostridium difficile associated diarrhea (CDAD) in adults and children aged 6 months and above. In order to reduce the development of drug-resistant bacteria and maintain the effectiveness of non damycin and other antibiotics, non damycin should only be used to treat infections that have been proven or strongly suspected to be caused by Clostridium difficile.

Company News

Research News

Drug news